糖尿病视网膜病变中的葡萄糖运输,运输器和新陈代谢
Chaoyang Zhang1, Limin Gu2, Hai Xie1
1Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine, Shanghai, China; National Clinical Research Center for Eye Diseases; Shanghai Clinical Research Center for Eye Diseases; Shanghai Key Clinical Specialty; Shanghai Key Laboratory of Ocular Fundus Diseases; Shanghai Engineering Center for Visual Science and Photomedicine; Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai Eye Research Institute, Shanghai, China.
糖尿病视网膜病变 (DR) 是导致失明的主要原因,由高血糖驱动. 本综述探讨了视网膜中改变的葡萄糖运输和新陈代谢如何导致DR病变,并提出了潜在的治疗策略.
科学领域:
- 眼科医生 眼科 眼科
- 代谢障碍 代谢障碍 代谢障碍
- 细胞生物学 细胞生物学
背景情况:
- 糖尿病视网膜病变 (DR) 是全球劳动年龄成人视力损失的主要原因.
- 高血糖引起的葡萄糖运输的改变是DR发展的核心.
- 通过血视网膜屏障 (BRB) 运输葡萄糖对于视网膜健康至关重要.
研究的目的:
- 审查DR中葡萄糖运输和代谢的变化.
- 检查葡萄糖载体 (GLUT,SGLT,SWEET) 在DR中的作用.
- 讨论这些变化如何影响视网膜神经血管单元 (NVU),并建议治疗方法.
主要方法:
- 文献综述侧重于视网膜中的葡萄糖运输机制.
- 对DR中高血糖受影响的生物化学途径的分析.
- 讨论代谢变化与DR病理之间的联系.
主要成果:
- 高血糖症增加了视网膜的葡萄糖吸收,并激活了有害的途径 (PKC,AGE,多,HBP).
- 这些途径产生活性氧物种 (ROS),导致氧化应激和PARP激活.
- 激活的PARP有助于视网膜微血管病变,神经退行和DR的炎症.
结论:
- 改变葡萄糖运输和新陈代谢是DR的关键驱动因素.
- 准葡萄糖运输和相关途径可能为DR提供治疗效益.
- 了解这些机制对于开发有效的DR疗法至关重要.
相关概念视频
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Glucose Absorption Into the Small Intestine
Secondary Active Transport
Diabetes Mellitus: Type 2 and Gestational
Membrane Proteins
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...


